Navigation Links
PharmaNet Announces Tender Offer and Consent Solicitation
Date:5/27/2011

PRINCETON, N.J., May 27, 2011 /PRNewswire/ -- PharmaNet Development Group, Inc. (the "Company" or "PharmaNet") announced today that it has commenced a cash tender offer and consent solicitation (the "Offer") for any and all of its outstanding 10 7/8% Senior Secured Notes due 2017 (the "Notes"). The Offer is described in the Offer to Purchase and Consent Solicitation Statement dated May 26, 2011 (the "Offer to Purchase"). The Offer will expire at midnight, New York City time, on June 23, 2011, unless extended or earlier terminated (the "Expiration Time").

Holders who validly tender and do not validly withdraw their Notes and provide their consents to the proposed amendments to the indenture governing the Notes on or prior to the consent payment deadline of 5:00 p.m., New York City time, on June 9, 2011, unless extended or earlier terminated (the "Consent Payment Deadline"), shall receive the total consideration equal to $1,247.75 per $1,000 principal amount of Notes tendered (the "Total Consideration"), plus any accrued and unpaid interest on the Notes from the most recent interest payment date for the Notes up to, but not including, the payment date for such Notes.  The Total Consideration is a premium to the estimated weighted average of the "equity claw" and "make whole" redemption prices pursuant to the indenture governing the Notes.  Included in the $1,247.75 of the Total Consideration is a consent payment of $50.00 per $1,000 principal amount of Notes (the "Consent Payment"). If the Company is unsuccessful in consummating the Offer, PharmaNet intends to issue equity securities and to use the proceeds to redeem up to 35% of the Notes using the "equity claw" and to redeem the remaining outstanding Notes at the "make whole" premium.

Holders who validly tender their Notes after the Consent Payment Deadline, but on or prior to the Expiration Time, shall receive the tender offer consideration equal to $1,197.75 per $1,000 principal amount o
'/>"/>

SOURCE PharmaNet Development Group, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. PharmaNet to Present More Than 20 Posters at the 2010 American Association of Pharmaceutical Scientists Annual Meeting
2. PharmaNet Development Group Experts to Share Insights at the 9th Annual Partnerships in Clinical Trials Conference in Vienna
3. PharmaNet Development Group Appoints Anthony Maida, Vice President, Clinical Research
4. Stephen Kasay Joins PharmaNet Development Group as Chief Information Officer
5. SEC Closes Investigation of PharmaNet Development Group and Recommends No Action
6. Christopher Brennan Joins PharmaNet Development Group as General Counsel
7. PharmaNet Development Group Provides Financial Update and Announces Geographic Expansion
8. PharmaNet Development Group Clinical Research Experts to Present at Global Professional Meetings in June
9. PharmaNet Development Group Gives Notice of Anticipated Fundamental Change and Merger to Holders of Its Convertible Notes
10. PharmaNet Development Group, Inc. Expands Latin America Operations with Opening of Brazil Office
11. An Affiliate of JLL Partners, Inc. Commences Cash Tender Offer to Acquire PharmaNet Development Group, Inc. at $5.00 per Share
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... , July 29, 2015  Therapath Neuropathology ( ... increased partnerships with VA and Military Medical centers ... Fiber Density (ENFD) and Sweat Gland Nerve Fiber ... neuropathy ( https://therapath.com/skin ). Demonstration ... Density (ENFD) on punch skin biopsy is a ...
(Date:7/29/2015)... 29, 2015 /PRNewswire/ - RepliCel Life Sciences Inc. (OTCQB: ... company, is pleased to announce that the final design ... been locked.  Prototypes for industrial and regulatory testing ... application for CE mark clearance to market the ... 2016. (Photo: http://photos.prnewswire.com/prnh/20150729/248373 )  ...
(Date:7/29/2015)... ... 2015 , ... Available in select spas and http://www.lespausa.com ... product that targets fat cells for extreme contouring action. During sleep key ingredient ... inhibiting the formation of new fat. Upon waking CHRONODIET breaks down fat cells’ ...
(Date:7/29/2015)... Littleton, MA (PRWEB) , ... July 29, 2015 , ... ... range of serious diseases. Yet few people realize that a rich source of these ... or young adults, and teeth that need to be pulled to make room for ...
Breaking Biology Technology:Neuropathology services for VA and Military health systems 2RepliCel Life Sciences Unveils Innovative Dermal Injector Prototype 2RepliCel Life Sciences Unveils Innovative Dermal Injector Prototype 3RepliCel Life Sciences Unveils Innovative Dermal Injector Prototype 4RepliCel Life Sciences Unveils Innovative Dermal Injector Prototype 5Phytocéane introduces CHRONO NIGHT Express Contouring Bi-Gel 2Phytocéane introduces CHRONO NIGHT Express Contouring Bi-Gel 3Advanced Oral and Maxillofacial Surgery (AOMS) in Elmhurst, IL Partners with Provia Labs to make Store-A-Tooth™ Dental Stem Cell Banking Available to their Patients 2
... FREMONT, Calif., Sept. 10 WaferGen Biosystems, Inc. ... expression and genotyping systems, announced that the company has closed ... through August 31, 2009. WaferGen issued shares of the ... private placement offerings for total gross proceeds of approximately $6.2 ...
... , NEW HAVEN, Conn., Sept. 10 ... company focused on the discovery, development and commercialization of ... infections, today announced that seven posters have been accepted ... Agents and Chemotherapy (ICAAC) taking place in San Francisco, ...
... England, September 10 PharmaVentures announced,today the appointment ... & Portfolio,Strategy Practice of Corporate Advisory, leading a ... Fintan Walton, PhD, PharmaVentures, Chief Executive ... PharmaVentures. Our Corporate Advisory business,is currently undergoing exciting ...
Cached Biology Technology:WaferGen Closes on Private Financings of Approx. $6.2 Million 2WaferGen Closes on Private Financings of Approx. $6.2 Million 3Rib-X Pharmaceuticals to Present at the 49th ICAAC 2Rib-X Pharmaceuticals to Present at the 49th ICAAC 3Rib-X Pharmaceuticals to Present at the 49th ICAAC 4PharmaVentures Corporate Advisory Appoints Nikki Watkins as Practice Head, Product & Portfolio Strategy 2
(Date:6/25/2015)... According to a new ... Area), Technology, Material (Optical Prism, Piezoelectric, Capacitive & ... Others) & Geography - Global Forecast to 2014 ... is expected to reach $14,500.07 Million by 2020, ... Browse 76 market Tables and 109 Figures spread ...
(Date:6/24/2015)... NEW YORK , June 24, 2015 ... Systems market, over the next six years. It contains ... affect the industry, along with their impact from the ... It also discusses the industry, market, and technology ... expected that the need of concerned authorities to efficiently ...
(Date:6/23/2015)... June 23, 2015   MedNet Solutions , ... the entire spectrum of clinical research, is pleased ... ™ , the company,s intuitive, flexible and affordable ... Silver 2015 Stevie® Award by the American ... Services Website category.  The American Business Awards are ...
Breaking Biology News(10 mins):Fingerprint Sensors Market Worth $14,500.07 Million by 2020 2Fingerprint Sensors Market Worth $14,500.07 Million by 2020 3Fingerprint Sensors Market Worth $14,500.07 Million by 2020 4Automatic Identification System Market by Class, by Platform, by Application and by Geography - Global Forecasts & Analysis to 2014 - 2020 2MedNet Solutions' iMedNet eClinical Wins Silver Stevie Award 2
... Feb. 8, 2013 Genes that have roles in the ... a finding that could be used to discover their functions, ... Medicine in the February issue of GENETICS . ... but the functions of most of those genes have not ...
... 1. Scientists from Singapore and Germany have identified that the ... are essential for holding silent genes in their correct ... form of heterochromatin . A deviation from their normal ... heart failure, vascular disease and muscle wasting. ...
... UT Arlington bioengineer has been awarded a $407,163 National ... and sound to produce an accurate image of a ... bioengineering at The University of Texas at Arlington, said ... in deep tissue. , Currently, to analyze tissue more ...
Cached Biology News:Evaluating evolutionary rates could shed light into functions of uncharacterized genes 2A*STAR scientists' groundbreaking discovery of nucleus structure crucial to understanding diseases 2UT Arlington bioengineer to use hybrid imaging system to see deep tissue 2
... SYBR Green II RNA gel stain ... stain that has bright fluorescence when bound ... making it ideal for use with either ... or standard UV transilluminators. A 500 µL ...
... The software records analyzes and reports the ... The software replaces the a chart recorder. The ... the software program. The end-point selection is automatic ... values are automatically computed. The user is always ...
... HT is taking automated patch clamping to a ... ability to generate thousands of high quality data ... paradigms in ion channel drug discovery and safety ... quality afforded by conventional patch clamping can now ...
... mouse embryonic stem cells to dopaminergic neurons. ... where they are mainly located in the ... the retrorubral field. These dopaminergic (DA) neurons ... ( e.g.projections to the caudate nucleus, putamen ...
Biology Products: